The Paired Basic Amino Acid-cleaving Enzyme 4 (PACE4) Is Involved in the Maturation of Insulin Receptor Isoform B

AN OPPORTUNITY TO REDUCE THE SPECIFIC INSULIN RECEPTOR-DEPENDENT EFFECTS OF INSULIN-LIKE GROWTH FACTOR 2 (IGF2)*

  1. Franck Peiretti4
  1. From the INSERM 1062, INRA 1260, Aix-Marseille Université, Faculté de médecine, F-13385, Marseille, France,
  2. §Nuolan Net, 1098 Amsterdam, The Netherlands,
  3. the Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, SE-17176 Stockholm, Sweden,
  4. the Institut de Pharmacologie de Sherbrooke, Département de Chirurgie/Urologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada, and
  5. the **Laboratory of Biochemical Neuroendocrinology Center for Human Genetics, Katholieke Universiteit Leuven, 3000 Leuven, Belgium
  1. 4 To whom correspondence should be addressed: INSERM 1062, INRA 1260, Aix-Marseille Université, Faculté de Médecine, 27 Blvd. Jean Moulin; 13385 Marseille Cedex 05, France. Tel.: 33-4-91324508; Fax: 33-4-91254336; E-mail: franck.peiretti{at}univ-amu.fr.

Background: The insulin receptor exists as two isoforms: IRA and IRB.

Results: IRA and IRB are similarly matured by furin, but when furin activity is reduced, IRB is matured by PACE4.

Conclusion: Proprotein convertase inhibition can selectively reduce IRA maturation and its signaling.

Significance: This can be considered as a new opportunity to target IRA signaling in cancer.

Abstract

Gaining the full activity of the insulin receptor (IR) requires the proteolytic cleavage of its proform by intra-Golgi furin-like activity. In mammalian cells, IR is expressed as two isoforms (IRB and IRA) that are responsible for insulin action. However, only IRA transmits the growth-promoting and mitogenic effects of insulin-like growth factor 2. Here we demonstrate that the two IR isoforms are similarly cleaved by furin, but when this furin-dependent maturation is inefficient, IR proforms move to the cell surface where the proprotein convertase PACE4 selectively supports IRB maturation. Therefore, in situations of impaired furin activity, the proteolytic maturation of IRB is greater than that of IRA, and accordingly, the amount of phosphorylated IRB is also greater than that of IRA. We highlight the ability of a particular proprotein convertase inhibitor to effectively reduce the maturation of IRA and its associated mitogenic signaling without altering the signals emanating from IRB. In conclusion, the selective PACE4-dependent maturation of IRB occurs when furin activity is reduced; accordingly, the pharmacological inhibition of furin reduces IRA maturation and its mitogenic potential without altering the insulin effects.

Footnotes

  • 1 Recipient of a grant from the Ministère de la Recherche et de l'Enseignement Supérieur.

  • 2 Supported by Prostate Cancer Canada Grants D2013-8, 2012-951, and TAG2014-02 and Canadian Cancer Society Research Institute Grant 701590.

  • 3 Supported by Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen.

  • * This work was supported by INSERM, INRA, and Aix-Marseille Université.

  • Received July 3, 2014.
  • Revision received December 10, 2014.
Table of Contents

This Article

  1. The Journal of Biological Chemistry 290, 2812-2821.
  1. All Versions of this Article:
    1. M114.592543v1
    2. 290/5/2812 (most recent)

Article Usage Stats

Submit your work to JBC.

You'll be in good company.